MYELOID-DERIVED GROWTH FACTOR FOR USE IN TREATING OR PREVENTING FIBROSIS, HYPERTROPHY OR… Application WO-2021148411-A1 World Intellectual Property Organisation (WIPO) 29 Jul 2021